| Financial Year |
March 31 2023 |
| Monetary Funds |
453,745,437.41 |
| Held-for-trading Financial Assets |
1,237,896,969.00 |
| Notes Receivable |
74,629,000.35 |
| Accounts Receivable |
120,260,216.70 |
| Advances to Suppliers |
15,067,015.19 |
| Other Receivables |
1,444.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
158,804,414.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,816,806.77 |
| Total Current Assets |
2,079,945,079.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
392,092,630.58 |
| Under-construction Projects |
132,076,967.59 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
100,634,823.01 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
12,914,948.55 |
| Other Non-Current Assets |
5,662,279.35 |
| Sub-Total of Non-Current Assets |
643,381,649.08 |
| Total Assets |
2,723,326,728.85 |
| Short-Term Loans |
13,311,947.83 |
| Trading Financial liabilities |
-- |
| Notes Payable |
98,263,160.95 |
| Accounts Payable |
41,466,545.38 |
| Accounts Received In Advance |
264,683.25 |
| Employee Compensation Payable |
3,047,012.03 |
| Taxes Payable |
19,748,669.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,395.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
26,555,176.65 |
| Sub-Total of Current Liabilities |
205,753,650.09 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,111,992.99 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
85,137,184.09 |
| Total Liabilities |
290,890,834.18 |
| Paid-In Capital(Or Share Stock) |
225,562,000.00 |
| Capital Surplus |
1,232,328,014.31 |
| Surplus Reserve |
132,013,534.35 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
811,590,586.83 |
| Minority Stockholder's Interest |
29,836,603.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,402,599,291.37 |
| Owner's Equity（Stockholder's Equity） |
2,432,435,894.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,723,326,728.85 |
